Exploring mortality among drug treatment clients: The relationship between treatment type and mortality
|dc.identifier.citation||Lloyd, B. and Zahnow, R. and Barratt, M. and Best, D. and Lubman, D. and Ferris, J. 2017. Exploring mortality among drug treatment clients: The relationship between treatment type and mortality. Journal of Substance Abuse Treatment. 82: pp. 22-28.|
© 2017 Aims Studies consistently identify substance treatment populations as more likely to die prematurely compared with age-matched general population, with mortality risk higher out-of-treatment than in-treatment. While opioid-using pharmacotherapy cohorts have been studied extensively, less evidence exists regarding effects of other treatment types, and clients in treatment for other drugs. This paper examines mortality during and following treatment across treatment modalities. Methods A retrospective seven-year cohort was utilised to examine mortality during and in the two years following treatment among clients from Victoria, Australia, recorded on the Alcohol and Drug Information Service database by linking with National Death Index. 18,686 clients over a 12-month period were included. Crude (CMRs) and standardised mortality rates (SMRs) were analysed in terms of treatment modality, and time in or out of treatment. Results Higher risk of premature death was associated with residential withdrawal as the last type of treatment engagement, while mortality following counselling was significantly lower than all other treatment types in the year post-treatment. Both CMRs and SMRs were significantly higher in-treatment than post-treatment. Conclusion Better understanding of factors contributing to elevated mortality risk for clients engaged in, and following treatment, is needed to ensure that treatment systems provide optimal outcomes during and after treatment.
|dc.title||Exploring mortality among drug treatment clients: The relationship between treatment type and mortality|
|dcterms.source.title||Journal of Substance Abuse Treatment|
|curtin.department||National Drug Research Institute (NDRI)|
|curtin.accessStatus||Fulltext not available|
Files in this item
There are no files associated with this item.